QUEBEC CITY, Feb. 19 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.
(NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on
endocrine therapy and oncology, today announced that its President and CEO,
David J. Mazzo, Ph.D., will present a company overview at the Roth Capital
Partners 20th Annual OC Growth Stock Conference on February 20, 2008 at
4:00 pm PT, in the Ballroom of the Ritz Carlton Laguna Niguel in Dana
Point, California.
A live webcast of this presentation will be available on AEterna
Zentaris' website at http://www.aezsinc.com in the Investors section. A replay
will also be available for a period of 30 days on the Company's website.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at http://www.aezsinc.com.
'/>"/>SOURCE AETERNA ZENTARIS INC. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 Related biology technology :1.
AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers2.
AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment3.
AEterna Zentaris Announces Outcome of Managements Strategic Review4.
AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York5.
AEterna Zentaris completes management team with the appointment of Chief Medical Officer6.
AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference7.
Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting8.
PLC Systems to Present at the ROTH Conference9.
Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference10.
CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference11.
ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells